Alexander Röth (@roethal) header
Alexander Röth (@roethal) profile picture

Alexander Röth

@roethal
Joined January 2017
  • Tweets198
  • Following344
  • Followers115
38Media
Photo by Alexander Röth (@roethal)Photo by Alexander Röth (@roethal)Photo by Alexander Röth (@roethal)Photo by Alexander Röth (@roethal)Photo by Alexander Röth (@roethal)Photo by Alexander Röth (@roethal)Photo by Alexander Röth (@roethal)Photo by Alexander Röth (@roethal)Photo by Alexander Röth (@roethal)Photo by Alexander Röth (@roethal)
This masterpiece was shot on a train. The train maintains an average speed of roughly 100-170 km/h (62-106 mph). This was intense from start to finish❄💥
Proper Radgie 🤝 Massive Softie = A Peng Ting (@AttaBoi_Westy) profile pictureProper Radgie 🤝 Massive Softie = A Peng Ting@AttaBoi_WestyFeb 27
When Jules found out the man she's been messing around with is Nate's dad 🤯
46
86
19
1,170
81,932
Alexander Röth retweeted
Alexander Röth (@roethal) profile picture
Alexander Röth@roethal11 Dec 2025
Hot of the press: #iptacopan for #ITP and #CAD: American Journal of Hematology | Blood Research Journal | Wiley Online Library onlinelibrary.wiley.com/doi/…
Iptacopan for Immune Thrombocytopenia and Cold Agglutinin Disease: A Global Phase 2 Basket Clinical...

Iptacopan for Immune Thrombocytopenia and Cold Agglutinin Disease: A Global Phase 2 Basket Clinical...

Iptacopan is a first-in-class, oral, selective inhibitor of complement factor B that has demonstrated positive efficacy across several complement-driven diseases. Here we evaluate the efficacy and...

onlinelibrary.wiley.com
1
44
Hot of the press: #iptacopan for #ITP and #CAD: American Journal of Hematology | Blood Research Journal | Wiley Online Library onlinelibrary.wiley.com/doi/…
Iptacopan for Immune Thrombocytopenia and Cold Agglutinin Disease: A Global Phase 2 Basket Clinical...

Iptacopan for Immune Thrombocytopenia and Cold Agglutinin Disease: A Global Phase 2 Basket Clinical...

Iptacopan is a first-in-class, oral, selective inhibitor of complement factor B that has demonstrated positive efficacy across several complement-driven diseases. Here we evaluate the efficacy and...

onlinelibrary.wiley.com
1
44
Just published: The 48-week results of #iptacopan in #PNH: Oral iptacopan monotherapy in paroxysmal nocturnal haemoglobinuria: fi... sciencedirect.com/science/ar…
67
Alexander Röth retweeted
Robert Brodsky (@DocsDock200) profile picture
Robert Brodsky@DocsDock2005 Mar 2025
Image from Robert Brodsky (@DocsDock200)
1
10
809
Alexander Röth retweeted
Robert Brodsky (@DocsDock200) profile picture
Robert Brodsky@DocsDock20021 Feb 2025
search.app/WV3jEBGYxRiFyWB37 Amazed that we now have 6 drugs to treat PNH. Earlier this century 0.
Image from Robert Brodsky (@DocsDock200)
1
1
16
1,294
Imetelstat: a new addition to the therapeutic landscape of lower-risk MDS ow.ly/Evny50UQIy0 #clinicaltrialsandobservations #myeloidneoplasia #bloodspotlight
Image from Blood Journals Portfolio (@BloodPortfolio)
18
39
4,640
Alexander Röth retweeted
Jeff Szer (@marrow) profile picture
Jeff Szer@marrow31 Jan 2025
Interested in #PNH? Join us in Paris for the 2nd Scientific Conference on PNH! 📅 Dates: May 15-16, 2025 📍 Location: Novotel Paris Centre Eiffel Tower. ipig2025.com/program
Image from Jeff Szer (@marrow)
1
4
224
Pegcetacoplan treatment increased Hb levels, reduced hemolysis, and increased FACIT-fatigue scale scores in patients with CAD and wAIHA. ow.ly/wBH150UMeUL #clinicaltrialsandobservations #immunobiologyandimmunotherapy #redcellsironanderythropoiesis
Image from Blood Journals Portfolio (@BloodPortfolio)
1
9
32
2,719
“Complementing” hemolytic anemias: what’s next? ow.ly/MBFL50UMbWO #clinicaltrialsandobservations
Image from Blood Journals Portfolio (@BloodPortfolio)
1
22
68
6,452
Alexander Röth retweeted
Emma M. Groarke (@emmamgroarke) profile picture
Emma M. Groarke@emmamgroarke27 Jan 2025
Nice review article from @BabushokLab on the pathophysiology of immune #AplasticAnemia
British Journal of Haematology (@BrJHaem) profile pictureBritish Journal of Haematology@BrJHaem27 Jan 2025
Origins of T-cell-mediated autoimmunity in acquired aplastic anaemia buff.ly/3Cp8ZXR
Image from British Journal of Haematology (@BrJHaem)
4
24
2,227
Important informations on how to manage BTH in #pnh from the anual IPIG meeting! #ASH24 @AustinKulasekar @scheinbp @lichterzellen @AAundPNHeV
Image from Alexander Röth (@roethal)
Image from Alexander Röth (@roethal)
Image from Alexander Röth (@roethal)
Image from Alexander Röth (@roethal)
2
2
9
406
Just out: #crovalimab in the #pnh treatment landscape! @AustinKulasekar @HamatologieUk @scheinbp doi.org/10.1080/1750743X.202…
Crovalimab in the paroxysmal nocturnal hemoglobinuria treatment landscape

Crovalimab in the paroxysmal nocturnal hemoglobinuria treatment landscape

Paroxysmal nocturnal hemoglobinuria (PNH) is an acquired, rare, life-threatening hematopoietic stem cell disorder that causes stem cell-derived cells to be vulnerable to complement-mediated lysis a...

tandfonline.com
2
96
Wir sind schon gespannt und freuen uns auf die 65. ASH-Jahrestagung 2024 in San Diego ✈️ Save the Date 2025 für unsere Hybridveranstaltung ! @chr_reinhardt @roethal @UniklinikEssen @MedEssen
Image from Hämatologie und Stammzelltransplantation, UK-Essen (@HamatologieUk)
2
5
1,070
Nach dem Seminar ist vor dem Seminar: Wir freuen uns schon auf das 16. Patienten- und Angehörigenseminar PNH und AA am 27. September 2025 in Essen! @AAundPNHeV @lichterzellen @HamatologieUk @MedEssen @aamdsif @GlobalPnh @PNHSupport @pnhaacontact @PNHCanada
Image from Alexander Röth (@roethal)
1
1
4
166
Safety of Crovalimab Versus Eculizumab in Patients With Paroxysmal Nocturnal Haemoglobinuria (PNH): Pooled Results From the Phase 3 COMMODORE Studies - Röth - European Journal of Haematology - Wiley Online Library onlinelibrary.wiley.com/doi/…
Safety of Crovalimab Versus Eculizumab in Patients With Paroxysmal Nocturnal Haemoglobinuria (PNH):...

Safety of Crovalimab Versus Eculizumab in Patients With Paroxysmal Nocturnal Haemoglobinuria (PNH):...

Objectives To evaluate the tolerability of crovalimab versus eculizumab in C5 inhibitor (C5i)-naive and -experienced patients with PNH from COMMODORE 2, 3 and 1 (NCT04434092, NCT04654468 and NCT044...

onlinelibrary.wiley.com
2
69
Massive hemolysis in paroxysmal nocturnal hemoglobinuria after switching from proximal complement inhibitor to anti-C5 therapy: A lesson not to be forgotten @AjHematology onlinelibrary.wiley.com/doi/…
Massive hemolysis in paroxysmal nocturnal hemoglobinuria after switching from proximal complement...

Massive hemolysis in paroxysmal nocturnal hemoglobinuria after switching from proximal complement...

Click on the article title to read more.

onlinelibrary.wiley.com
12
47
2,685
Am Samstag, den 21.09.2024 ist es soweit: Wir veranstalten unser 15. Essener Patienten- und Angehörigenseminar für #PNH und #AA. Wir freuen uns wieder auf eine spannende Veranstaltung! @lichterzellen @AAundPNHeV @UniklinikEssen @HamatologieUk dgho.de/veranstaltunge…
Image from Alexander Röth (@roethal)
3
4
229
#PNH #AA @lichterzellen @AAundPNHeV @HamatologieUk dgho.de/veranstaltungen/vera…
Image from Alexander Röth (@roethal)
1
3
73
Am Samstag, den 21.09.2024 ist es soweit: Wir veranstalten unser 15. Essener Patienten- und Angehörigenseminar für #PNH und #AA. Wir freuen uns auf eine spannende Veranstaltung! @lichterzellen @AAundPNHeV @UniklinikEssen @HamatologieUk dgho.de/veranstaltungen/vera…
1
4
110
Load more